Abstract
Serum anti-Müllerian hormone (AMH) level is a well-established marker of ovarian reserve and a good predictor of ovarian response after controlled ovarian hyperstimulation. However, literature is unclear whether its measurement can predict live birth (LB) in spontaneous or assisted conception. To clarify this issue, we undertook a systematic review and meta-analysis to analyze whether serum AMH level may predict the chances of LB in women having conceived naturally and/or the cumulative live birth (C.LB) in infertile women undergoing assisted reproductive technologies (ART).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
